相关实验视频

Updated: May 5, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

识别和分析肺腺癌中与氨基酸代谢相关的亚型

Yifan Zhou¹, Qiangchang Lu¹

¹Department of Thoracic Surgery, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China.

American journal of physiology. Regulatory, integrative and comparative physiology

|January 2, 2025

概括

这项研究确定了肺腺癌中两种与氨基酸代谢 (AAM) 相关的亚型. 集群1显示出更好的生存和免疫水平,而集群2对某些药物更为敏感.

科学领域:

在瘤学瘤学.
代谢学代谢学代谢学
生物信息学是一种生物信息学.

背景情况:

肺腺癌 (LUAD) 的预后和治疗需要新的生物标志物.
氨基酸代谢 (AAM) 在癌症发展中起着至关重要的作用.

研究的目的:

探索AAM在LUAD中的作用.
为了确定AAM相关的生物标志物用于预后,管理和治疗.

主要方法:

在LUAD中对AAM基因的差异基因表达分析.
使用ConsensusClusterPlus. 的子类型集群.
生存,免疫和丰富分析.
蛋白质与蛋白质相互作用网络的构建和枢纽基因的识别.

主要成果:

确定了163个与AAM相关的差异表达基因 (DEG) 和两个不同的LUAD亚型.
1集群的生存率和免疫透率高于2集群.
关键的枢纽基因 (F2,AHSG,APOA1) 显著影响了预后.
集群2表现出对特定化疗药物的敏感性增加.

结论:

确定了两种新型的AAM相关的LUAD亚型,具有差异性的预后和治疗影响.
在LUAD中建立了预测免疫状态和药物敏感性的生物标志物.
研究结果为个人化临床治疗策略提供了宝贵的见解.

关键词:

氨基酸代谢氨基酸代谢药物预测药物预测免疫水平免疫水平肺部腺癌瘤是什么?分子亚型分子亚型

更多相关视频

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Extraction of Aqueous Metabolites from Cultured Adherent Cells for Metabolomic Analysis by Capillary Electrophoresis-Mass Spectrometry

Published on: June 9, 2019

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...